Results 151 to 160 of about 26,674 (238)

Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval. [PDF]

open access: yesDiabetes
Sims EK   +13 more
europepmc   +1 more source

Steroid-sparing strategies for managing immune-related adverse events. [PDF]

open access: yesJ Immunother Cancer
Huang JJ   +4 more
europepmc   +1 more source

Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis [PDF]

open access: yes, 2017
Brigitte Gubler   +9 more
core   +1 more source

CTLA-4-Ig therapy preserves cardiac function following myocardial infarction with reperfusion. [PDF]

open access: yesCardiovasc Res
Noonan J   +22 more
europepmc   +1 more source

Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients [PDF]

open access: yes, 2015
Akinori Matsumori   +30 more
core   +1 more source

PO:06:084 | Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study

open access: yesReumatismo
Background. Abatacept has been suggested to be a safe and effective drug for the treatment of rheumatoid arthritis (RA) complicated by interstitial lung disease (ILD), one of the most severe extra-articular manifestations of RA. Objectives.
Società Italiana di Reumatologia
doaj  

Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis. [PDF]

open access: yesArthritis Rheumatol
Yap CF   +14 more
europepmc   +1 more source

Evaluating the osteoclastogenic potential of peripheral blood mononuclear cells in children with chronic nonbacterial osteomyelitis. [PDF]

open access: yesJBMR Plus
Bui JP   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy